FRANCESCONI, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 1.533
AS - Asia 9
SA - Sud America 2
Totale 1.544
Nazione #
IT - Italia 1.533
CN - Cina 8
AR - Argentina 1
BD - Bangladesh 1
BR - Brasile 1
Totale 1.544
Città #
Genoa 951
Genova 281
Vado Ligure 162
Rapallo 136
Beijing 3
Bordighera 3
Florianópolis 1
Tianjin 1
Totale 1.538
Nome #
Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR) 178
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives 145
State-of-the-art Review on the Antiparasitic Activity of Benzimidazole-based Derivatives: Facing Malaria, Leishmaniasis, and Trypanosomiasis 126
Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays 126
9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp) 123
Synthesis and biological evaluation of nitrogen heterocycle systems as potential antiviral agents 106
Journey on naphthoquinone and anthraquinone derivatives: New insights in alzheimer’s disease 89
Synthesis and biological evaluation of novel (thio)semicarbazone-based benzimidazoles as antiviral agents against human respiratory viruses 86
Probing In Silico the Benzimidazole Privileged Scaffold for the Development of Drug-like Anti-RSV Agents 77
Anti-α-glucosidase and antiglycation activities of α-mangostin and new xanthenone derivatives: Enzymatic kinetics and mechanistic insights through in vitro studies 75
Novel 1-amidino-4-phenylpiperazines as potent agonists at human taar1 receptor: Rational design, synthesis, biological evaluation and molecular docking studies 71
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment 68
Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease 67
Evidence of pyrimethamine and cycloguanil analogues as dual inhibitors of trypanosoma brucei pteridine reductase and dihydrofolate reductase 60
Antitarget, Anti-SARS-CoV‑2 Leads, Drugs, and the Drug Discovery−Genetics Alliance Perspective 56
Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti-Trypanosoma brucei Agents 50
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction 47
In Vitro Screening of an In-House Library of Structurally Distinct Chemotypes Towards the Identification of Novel SARS-CoV-2 Inhibitors 22
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agents 22
Identification of a theranostic prodrug candidate against glioblastoma 11
Totale 1.605
Categoria #
all - tutte 6.236
article - articoli 5.870
book - libri 0
conference - conferenze 29
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 3 5 5 5 7 9 7 12 10
2021/2022105 1 4 5 4 3 7 9 27 18 8 7 12
2022/2023162 11 5 8 15 24 28 1 15 31 2 16 6
2023/2024209 9 15 16 17 17 42 16 14 7 14 28 14
2024/2025481 12 23 11 14 71 41 73 99 12 29 42 54
2025/2026443 131 22 220 70 0 0 0 0 0 0 0 0
Totale 1.605